Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine + magnesium sulfate for postoperative fatigue after laparoscopic cholecystectomy
ChiCTR2500109385Phase 4Not yet recruiting
- Sponsor
- Huai'an Second Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esketamine and magnesium sulfate in postoperative fatigue, postoperative pain and sleep disorder (4 arms), sponsored by Huai'an Second Hospital. Primary endpoints: Christensen's Fatigue Scale and Identity-Consequence Fatigue Scale. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
esketaminemagnesium sulfate
03
Conditions
postoperative fatiguepostoperative painsleep disorder
Beyond the preview
Go deeper on ChiCTR2500109385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109385.